Net profit of Natco Pharma declined 27.06% to Rs 464.10 crore in the quarter ended June 2025 as against Rs 636.30 crore during the previous quarter ended June 2024. Sales declined 3.57% to Rs 1192.70 crore in the quarter ended June 2025 as against Rs 1236.90 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 1192.70 | 1236.90 | -4 |
| OPM % | 45.25 | 61.69 | - |
| PBDT | 596.70 | 798.40 | -25 |
| PBT | 542.90 | 758.00 | -28 |
| NP | 464.10 | 636.30 | -27 |